PT3218351T - Um método para a preparação, isolamento e purificação de formas farmaceuticamente aplicáveis de ahu-377 - Google Patents

Um método para a preparação, isolamento e purificação de formas farmaceuticamente aplicáveis de ahu-377

Info

Publication number
PT3218351T
PT3218351T PT15808087T PT15808087T PT3218351T PT 3218351 T PT3218351 T PT 3218351T PT 15808087 T PT15808087 T PT 15808087T PT 15808087 T PT15808087 T PT 15808087T PT 3218351 T PT3218351 T PT 3218351T
Authority
PT
Portugal
Prior art keywords
ahu
isolation
purification
preparation
pharmaceutically applicable
Prior art date
Application number
PT15808087T
Other languages
English (en)
Inventor
Halama Ales
Zvatora Pavel
Dammer Ondrej
Stach Jan
Zapadlo Michal
Krejcik Lukas
Voslar Michal
Original Assignee
Zentiva Ks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CZ2014-792A external-priority patent/CZ2014792A3/cs
Priority claimed from CZ2015-758A external-priority patent/CZ2015758A3/cs
Application filed by Zentiva Ks filed Critical Zentiva Ks
Publication of PT3218351T publication Critical patent/PT3218351T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/03—Monoamines
    • C07C211/06—Monoamines containing only n- or iso-propyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/03—Monoamines
    • C07C211/07—Monoamines containing one, two or three alkyl groups, each having the same number of carbon atoms in excess of three
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT15808087T 2014-11-14 2015-11-11 Um método para a preparação, isolamento e purificação de formas farmaceuticamente aplicáveis de ahu-377 PT3218351T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ2014-792A CZ2014792A3 (cs) 2014-11-14 2014-11-14 Způsob přípravy, izolace a čištění farmaceuticky využitelných forem AHU-377
CZ2015-758A CZ2015758A3 (cs) 2015-10-27 2015-10-27 Pevné formy vápenaté soli ethyl esteru (2R, 4S)-5-(bifenyl-4-yl)-4-[(3-karboxypropionyl)amino]-2-methylpentanové kyseliny, způsob jejich přípravy a použití

Publications (1)

Publication Number Publication Date
PT3218351T true PT3218351T (pt) 2019-09-26

Family

ID=54848362

Family Applications (1)

Application Number Title Priority Date Filing Date
PT15808087T PT3218351T (pt) 2014-11-14 2015-11-11 Um método para a preparação, isolamento e purificação de formas farmaceuticamente aplicáveis de ahu-377

Country Status (8)

Country Link
EP (1) EP3218351B1 (pt)
DK (1) DK3218351T3 (pt)
ES (1) ES2745157T3 (pt)
HU (1) HUE046278T2 (pt)
LT (1) LT3218351T (pt)
PL (1) PL3218351T3 (pt)
PT (1) PT3218351T (pt)
WO (1) WO2016074651A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2837084T3 (es) 2015-07-02 2021-06-29 Novartis Ag Sales de calcio se sacubitril
BR112018011788A2 (pt) * 2015-12-11 2018-12-04 Zentiva Ks formas sólidas de éster etílico de ácido (2r,4s)-5-(bifenil-4-il)-4-[(3-carboxipropionil)amino]-2-metil-pentanoico, seus sais e um método de preparação
WO2018040065A1 (zh) * 2016-09-02 2018-03-08 诺瑞特国际药业股份有限公司 缬沙坦二钠盐的晶型
US10683260B2 (en) 2016-09-07 2020-06-16 Nanjing Noratech Pharmaceuticals Co., Ltd. Crystalline form of sacubitril sodium salt
CN106496055A (zh) * 2016-10-09 2017-03-15 杭州科巢生物科技有限公司 一种抗心衰新药的关键组分沙库比曲的新合成方法
EP3522886A4 (en) * 2016-10-10 2020-02-19 Laurus Labs Limited STABLE AMORPHE FORM OF THE SACUBITRIL VALSARTAN TRINATRIUM COMPLEX AND METHOD FOR THE PRODUCTION THEREOF
BR112019008581A2 (pt) 2016-10-28 2019-09-17 Biocon Ltd sacubitril valsartana trissódica amorfa e processo para sua preparação
CN107188817A (zh) * 2017-05-22 2017-09-22 杭州瑞法康科技有限公司 一种高纯度沙库比曲半钙盐一水合物的新晶型及其制备方法
CN107602410A (zh) * 2017-09-13 2018-01-19 浙江三门恒康制药有限公司 沙库比曲钠盐的晶型ii及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217996A (en) 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
NZ533968A (en) 2002-01-17 2006-10-27 Novartis Ag Pharmaceutical compositions comprising valsartan and nep inhibitors
AR057882A1 (es) 2005-11-09 2007-12-26 Novartis Ag Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
EP1903027A1 (en) 2006-09-13 2008-03-26 Novartis AG Process for preparing biaryl substituted 4-amino-butyric acid or derivatives thereof and their use in the production of NEP inhibitors
AR064842A1 (es) 2007-01-12 2009-04-29 Mazzucco Gavieiro Maria Belen Pirrolidin-2-onas, y su uso en la preparacion de inhibidores de nep
PE20091364A1 (es) 2008-01-17 2009-10-13 Novartis Ag Proceso para la preparacion de inhibidores de nep
US9067883B2 (en) 2010-01-22 2015-06-30 Novartis Ag Intermediates of neutral endopeptidase inhibitors and preparation method thereof
BR112013004164A2 (pt) 2010-08-23 2016-05-10 Novartis Ag processo para a preparação de intermediários para a produção de inibidores da nep
SI2609071T1 (sl) 2010-08-23 2017-01-31 Novartis Ag Novi postopek za pripravo intermediatov, uporabnih za izdelavo NEP inhibitorjev
AR092278A1 (es) 2012-08-31 2015-04-08 Novartis Ag Proceso de obtencion de derivados n-acilicos de bifenil-alanina e intermediarios relacionados
CN105168205A (zh) * 2015-08-18 2015-12-23 泰力特医药（湖北）有限公司 一种血管紧张素ii受体和脑啡肽酶受体双重抑制剂lcz696的制备方法

Also Published As

Publication number Publication date
DK3218351T3 (da) 2019-09-16
EP3218351B1 (en) 2019-06-19
LT3218351T (lt) 2019-09-25
WO2016074651A1 (en) 2016-05-19
ES2745157T3 (es) 2020-02-27
EP3218351A1 (en) 2017-09-20
PL3218351T3 (pl) 2019-12-31
HUE046278T2 (hu) 2020-02-28

Similar Documents

Publication Publication Date Title
HRP20201847T1 (hr) Postupak za pripremu spoja diariltiohidantoina
PL3218351T3 (pl) Sposób wytwarzania, wyodrębniania i oczyszczania farmaceutycznie dopuszczalnych postaci AHU-377
EP3096763A4 (en) Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
GB201418017D0 (en) A system for, and method of, building a taxonomy
ZA201706795B (en) Process for the preparation of dicycloplatin
IL277068B (en) A cellular method for determining the potency of defibrotide
GB201420259D0 (en) A method of forming a beverage capsule, a beverage capsule and a beverage preparation system
EP3227298A4 (en) Process for the preparation of baricitinib and an intermediate thereof
EP3201171A4 (en) Method of preparing intermediate of salmeterol
EP3174878A4 (en) A process for the preparation of palbociclib
GB201420271D0 (en) A method of forming a beverage capsule, a beverage capsule, a beverage preparation system and a set of tools
GB2561089B (en) Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one
IL250223A0 (en) A method for the preparation of the pyrimidin-1-ol compound, and its intermediates
HUE043822T2 (hu) Eljárás glikolok elõállítására
EP3221320A4 (en) A process for the preparation of ibrutinib
IL247443B (en) Process for the preparation of 5-fluorotryptophol
HK1258181A1 (zh) 製備螯合劑的方法
SG10202111096SA (en) Process for preparing a crassocephalum crepidioides extract, extract prepared thereby and use of the extract